These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 343649

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Prevention of sudden death in ischemic heart disease].
    Tsolov Ts.
    Vutr Boles; 1980; 19(6):14-21. PubMed ID: 6111160
    [No Abstract] [Full Text] [Related]

  • 24. Evaluation of therapeutic modalities in patients with life threatening arrhythmias.
    Teo KK.
    Can J Cardiol; 1994 Apr; 10(3):333-8. PubMed ID: 8162531
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Antiarrhythmic drugs for ischemic heart disease.
    Koch-Weser J.
    Postgrad Med; 1976 May; 59(5):168-73. PubMed ID: 1264912
    [Abstract] [Full Text] [Related]

  • 27. [The variability and prognostic significance of ventricular hyperkinetic arrhythmias in the postinfarct: the considerations after the CAST. Cardiac Arrhythmia Suppression Trial].
    Furlanello F, Gramegna L.
    G Ital Cardiol; 1990 Jul; 20(7):615-7. PubMed ID: 2245899
    [No Abstract] [Full Text] [Related]

  • 28. Ventricular arrhythmia induction study.
    Freedman RA, Mason JW.
    Cardiovasc Clin; 1985 Jul; 15(1):215-29. PubMed ID: 3842328
    [No Abstract] [Full Text] [Related]

  • 29. [Ventricular arrhythmias: diagnosis and drug therapy].
    Schüpfer C, Gertsch M.
    Praxis (Bern 1994); 1996 May 14; 85(20):647-54. PubMed ID: 8685556
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Measuring antiarrhythmic drug efficacy by suppression of asymptomatic ventricular arrhythmias.
    Winkle RA.
    Ann Intern Med; 1979 Sep 14; 91(3):480-2. PubMed ID: 475177
    [No Abstract] [Full Text] [Related]

  • 34. Amiodarone: a late comer.
    Futterman LG, Lemberg L.
    Am J Crit Care; 1997 May 14; 6(3):233-9. PubMed ID: 9131203
    [Abstract] [Full Text] [Related]

  • 35. Clinical trials of antiarrhythmic drugs in postmyocardial infarction and congestive heart failure patients.
    Camm AJ, Yap YG.
    J Cardiovasc Pharmacol Ther; 2001 Jan 14; 6(1):99-106. PubMed ID: 11452341
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Rational use of antiarrhythmic drugs alone and in combination.
    Bigger JT, Giardina EG.
    Cardiovasc Clin; 1974 Jan 14; 6(2):103-17. PubMed ID: 4613454
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Antiarrhythmic vs. antifibrillatory activity of the basic diphenylhydantoin derivative 3-[3-(4-phenyl-1-piperidyl)propyl]-5-(4-methoxyphenyl)-5-phenylhydantoin hydrochloride.
    Lynch J, Montgomery D, Ventura A, Wilber D, Lucchesi BR.
    Arzneimittelforschung; 1986 Mar 14; 36(3):475-81. PubMed ID: 3707667
    [Abstract] [Full Text] [Related]

  • 40. Long-term antiarrhythmic pharmaco-therapy guided by Holter monitoring in patients with malignant ventricular arrhythmias and ischemic heart disease.
    Trusz-Gluza M, Gasior Z, Wnuk-Wojnar AM, Filipecki A, Szydło K, Giec L.
    Mater Med Pol; 1992 Mar 14; 24(4):229-32. PubMed ID: 1308049
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.